These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11679141)

  • 1. Heparin-like inhibitory activity to fibroblast growth factor-2 in wound fluids of patients with chronic skin ulcers and its modulation during wound healing.
    Landau Z; David M; Aviezer D; Yayon A
    Wound Repair Regen; 2001; 9(4):323-8. PubMed ID: 11679141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers.
    Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA
    J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors.
    Stanley AC; Park HY; Phillips TJ; Russakovsky V; Menzoian JO
    J Vasc Surg; 1997 Dec; 26(6):994-9; discussion 999-1001. PubMed ID: 9423715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant transforming growth factor-beta 1 modulation of biochemical and cellular events in healing of ulcer wounds.
    Chen TL; Bates RL; Xu Y; Ammann AJ; Beck LS
    J Invest Dermatol; 1992 Apr; 98(4):428-35. PubMed ID: 1548427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative capacity of venous ulcer wound fibroblasts in the presence of platelet-derived growth factor.
    Vasquez R; Marien BJ; Gram C; Goodwin DG; Menzoian JO; Raffetto JD
    Vasc Endovascular Surg; 2004; 38(4):355-60. PubMed ID: 15306954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF.
    Albrecht-Schgoer K; Schgoer W; Theurl M; Stanzl U; Lener D; Dejaco D; Zelger B; Franz WM; Kirchmair R
    Angiogenesis; 2014 Jan; 17(1):27-36. PubMed ID: 23918206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid.
    Raffetto JD; Mendez MV; Marien BJ; Byers HR; Phillips TJ; Park HY; Menzoian JO
    J Vasc Surg; 2001 Jun; 33(6):1233-41. PubMed ID: 11389423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers.
    Jude EB; Blakytny R; Bulmer J; Boulton AJ; Ferguson MW
    Diabet Med; 2002 Jun; 19(6):440-7. PubMed ID: 12060054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
    Senet P; Bon FX; Benbunan M; Bussel A; Traineau R; Calvo F; Dubertret L; Dosquet C
    J Vasc Surg; 2003 Dec; 38(6):1342-8. PubMed ID: 14681639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
    Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
    Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound chronicity and fibroblast senescence--implications for treatment.
    Harding KG; Moore K; Phillips TJ
    Int Wound J; 2005 Dec; 2(4):364-8. PubMed ID: 16618323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
    Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
    Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate.
    Hehenberger K; Heilborn JD; Brismar K; Hansson A
    Wound Repair Regen; 1998; 6(2):135-41. PubMed ID: 9776856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cultured allogeneic skin cells are effective in the treatment of chronic diabetic leg and foot ulcers.
    Harvima IT; Virnes S; Kauppinen L; Huttunen M; Kivinen P; Niskanen L; Horsmanheimo M
    Acta Derm Venereol; 1999 May; 79(3):217-20. PubMed ID: 10384921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic wound fluid on fibroblasts.
    Phillips TJ; Al-Amoudi HO; Leverkus M; Park HY
    J Wound Care; 1998 Nov; 7(10):527-32. PubMed ID: 10188448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer wound fluid: A potential mechanism for senescence in venous ulcers.
    Mendez MV; Raffetto JD; Phillips T; Menzoian JO; Park HY
    J Vasc Surg; 1999 Oct; 30(4):734-43. PubMed ID: 10514213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human fibroblast-derived dermis on expansion of tissue from venous leg ulcers.
    Martin TA; Hilton J; Jiang WG; Harding K
    Wound Repair Regen; 2003; 11(4):292-6. PubMed ID: 12846917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers.
    Drinkwater SL; Burnand KG; Ding R; Smith A
    J Vasc Surg; 2003 Nov; 38(5):1106-12. PubMed ID: 14603223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review.
    Zubair M; Ahmad J
    Rev Endocr Metab Disord; 2019 Jun; 20(2):207-217. PubMed ID: 30937614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.